83B.F 3SBio Inc

Healthcare Biotechnology Frankfurt Exchange
1.67 EUR
Close of Nov 12, 2026
1.47 3.72
Market cap
EUR 4.14B
P/E
4.1x
P/B
1.13x
ROE
31.2%
Dividend yield
1.66%
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is 83B.F undervalued?

Graham number
Price1.67
Graham value3.70
Discount54.8%

83B.F trades 54.8% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

3SBio Inc fundamental analysis

No fundamental analysis for 3SBio Inc yet.

3SBio Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About 3SBio Inc

3SBio Inc., an investment holding company, engages in the development, production, marketing, and sale of biopharmaceutical products in the People's Republic of China, the United States, and internationally. The company offers TPIAO bio-pharmaceutical drug for the treatment of chemotherapy-induced thrombocytopenia, immune thrombocytopenia, pediatric ITP, and chronic liver disease-related thrombocytopenia. It also provides EPIAO for indications, such as the treatment of anemi…

Full company profile